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Essential omega-3 fatty acids tune microglial
phagocytosis of synaptic elements in the mouse
developing brain
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Omega-3 fatty acids (n-3 PUFAs) are essential for the functional maturation of the brain.
Westernization of dietary habits in both developed and developing countries is accompanied
by a progressive reduction in dietary intake of n-3 PUFAs. Low maternal intake of n-3 PUFAs
has been linked to neurodevelopmental diseases in Humans. However, the n-3 PUFAs
deficiency-mediated mechanisms affecting the development of the central nervous system
are poorly understood. Active microglial engulfment of synapses regulates brain develop-
ment. Impaired synaptic pruning is associated with several neurodevelopmental disorders.
Here, we identify a molecular mechanism for detrimental effects of low maternal n-3 PUFA
intake on hippocampal development in mice. Our results show that maternal dietary n-3
PUFA deficiency increases microglia-mediated phagocytosis of synaptic elements in the
rodent developing hippocampus, partly through the activation of 12/15-lipoxygenase (LOX)/
12-HETE signaling, altering neuronal morphology and affecting cognitive performance of the
offspring. These findings provide a mechanistic insight into neurodevelopmental defects
caused by maternal n-3 PUFAs dietary deficiency.
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Lipids are one of the main constituents of the central nervoussystem (CNS). Among these, arachidonic acid (AA, 20:4n-6)and docosahexaenoic acid (DHA, 22:6n-3) are the principal
forms of the long chain (LC) polyunsaturated fatty acids, omega-6
and omega-3 (referred to as n-6 or n-3 PUFAs) of the grey matter.
These two LC PUFAs are found predominantly in the form of
phospholipids and constitute the building blocks of brain cell
membranes1. AA and DHA are either biosynthesized from their
respective dietary precursors, linoleic acid (LA, 18:2n-6), and α-
linolenic acid (ALA, 18:3n-3), or directly sourced from the diet
(mainly meat and dairy products for AA, fatty fish for DHA)2. In
addition, AA and DHA are crucial for cell signaling through a
variety of bioactive mediators. These mediators include oxylipins
derived from cyclooxygenases (COX), lipoxygenases (LOX), and
cytochrome P450 (CYP) pathways1 that are involved in the reg-
ulation of inflammation and phagocytic activity of immune cells3–6.
An overall increase in the dietary LA/ALA ratio and a reduction in
LC n-3 PUFA intake, as found in the Western diet, leads to reduced
DHA and increased AA levels in the brain7.
DHA is essential for the functional maturation of brain
structures8. Low n-3 PUFA consumption globally has raised
concerns about its potential detrimental effects on the neurode-
velopment of human infants9 and the incidence of neurodeve-
lopmental diseases, such as Autism Spectrum Disorder (ASD)
and schizophrenia10.
To understand the mechanisms by which n-3/n-6 PUFA
imbalance affects CNS development, we investigated the impact
of maternal dietary n-3 PUFA deficiency on offspring’s microglia,
the resident immune cells involved in CNS development and
homeostasis11. Microglia are efficient phagocytes of synaptic
material and apoptotic cells, which are key processes in the
developing brain12. Specifically, once neuronal circuits are
established, microglia contribute to the refinement of synaptic
connections by engulfing synaptic elements in early post-natal
life, in a fractalkine- and complement cascade-dependent man-
ner13–15. This refinement is important for behavioral adaptation
to the environment16.
We have previously reported that a maternal dietary n-3 PUFA
deficiency alters the microglial phenotype and reduces their
motility in the developing hippocampus17. Therefore, we inves-
tigated the effect of maternal (i.e. gestation and lactation) n-3
PUFA deficiency on microglial function and its consequences on
hippocampal development. Using multidisciplinary approaches,
we reveal that maternal exposure to an n-3 PUFA deficient diet
impairs offspring’s microglial homeostatic signature and phago-
cytic activity, underpinning excessive synaptic pruning and sub-
sequent behavioral abnormalities. N-3 PUFA deficiency drives
excessive microglial phagocytosis of synaptic elements through
the oxylipin 12/15-LOX/12-HETE pathway and is a key
mechanism contributing to microglia-mediated synaptic remo-
deling in the developing brain. These results highlight the impact
of bioactive fatty acid mediators on brain development and
identify imbalanced nutrition as a potent environmental risk
factor for neurodevelopmental disorders.
Results
Maternal dietary n-3 PUFA deficiency alters the morphology of
hippocampal neurons and hippocampal-mediated spatial
working memory. The hippocampus plays an essential role in
learning and memory, with the neurons of the CA1 region required
for spatial working memory. Therefore, we assessed the effects of
maternal dietary n-3 PUFA deficiency on neuronal morphology in
the offspring hippocampus CA1 using Golgi-Cox staining at post-
natal day (P)21. Dendritic spine density of Golgi-stained CA1
pyramidal neurons was significantly decreased in n-3 deficient mice
compared to n-3 sufficient mice (Fig. 1a, b). This was associated
with a decrease in the length of dendrites, whereas the complexity
of dendritic arborization was unchanged (Fig. 1a, b). Western blot
analyses on whole hippocampi showed a significant decrease in the
expression of the post-synaptic scaffold proteins PSD-95 and
Cofilin, but not of SAP102, in n-3 deficient vs. n-3 sufficient mice
(Fig. 1c, d). AMPA and NMDA subunit expression levels were
unaffected (Supplementary Fig. 1A, B). In the Y-maze task, a
hippocampus-dependent test assessing spatial working memory,
P21 n-3 deficient mice were unable to discriminate between the
novel and familiar arms of the maze, unlike the n-3 sufficient mice
(Fig. 1e). These data show that maternal n-3 PUFA deficiency
disrupts early-life (P21) spine density, neuronal morphology and
alters spatial working memory.
Maternal dietary n-3 PUFA deficiency increases microglia-
mediated synaptic loss. As microglia phagocytose pre- and post-
synaptic elements to shape neural networks13,14, we used electron
microscopy (EM) to analyze, at high spatial resolution,
microglia–synapse interactions in the hippocampal CA1 region of
n-3 deficient vs. n-3 sufficient mice (Fig. 2a, b). At P21, i.e. at the
peak of hippocampal synaptic pruning18, we found significantly
more contacts between Iba1-positive microglial processes and the
synaptic cleft and more dendritic spine inclusions within those
processes in n-3 deficient mice (Fig. 2b). Microglial processes
from n-3 deficient mice contained more inclusions within
endosomes such as spines and other cellular elements, along with
a reduced accumulation of debris in the extracellular space, thus
suggesting an increase in phagocytic activity16 (Fig. 2a, b). This
was not due to changes in microglial process size, as diet did not
affect process morphology (Supplementary Fig. 2A). In addition,
confocal imaging and 3D reconstruction of microglia showed that
PSD95-immunoreactive puncta within Iba1-positive microglia
were more abundant in the hippocampus of n-3 deficient mice,
corroborating the EM data (Fig. 2c, d). To provide further sup-
port to this increase in microglial phagocytosis, we stimulated
ex vivo hippocampal microglia from n-3 deficient vs. n-3
sufficient P21 mice with pHrodo E.Coli bioparticles. The
pHrodo dye-labelled E. coli becomes fluorescent upon entering
acidic phagosomes, enabling the assessment of phagocytic activity
of microglia. The results revealed that the percentage of phago-
cytic microglia is significantly higher in n-3 deficient mice across
the time points studied (Fig. 2e, f and Supplementary Fig. 2B).
Increased microglial phagocytosis in the hippocampus was not a
compensation to a decrease in microglial density, as there were no
differences in microglial density assessed by stereological count-
ing in the different hippocampal sub-regions, including the CA1
(Supplementary Fig. 2C, D).
Enhanced microglial phagocytic activity was also not linked to an
increase in cell death, as the volume of the hippocampus, number of
neurons and astrocytes, number of apoptotic cells and expression of
pro-apoptotic protein Bax and anti-apoptotic protein Bcl-2 were
not different between diets (Supplementary Fig. 3A–F). Further-
more, it is unlikely that n-3 PUFA deficiency-induced increase in
phagocytosis resulted from brain infiltration of peripherally-derived
macrophages. This is consistent with the observation that maternal
n-3 PUFA deficiency did not modulate the number of CD11b-high/
CD45-high cells within the whole brain (Supplementary Fig. 3G)
and that the blood-brain barrier was intact in both diet groups as
revealed by the expression of Claudin-5 and GFAP as well as IgG
extravasation (Supplementary Fig. 3H–M).
Maternal dietary n-3 PUFA deficiency dysregulates microglial
homeostasis. During brain development, microglia display a
unique transcriptomic signature that supports their physiological
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functions, including in synaptic refinement19. Therefore, we
investigated whether and how n-3 PUFA deficiency modulates
the homeostatic molecular signature of microglia isolated from n-
3 deficient vs. n-3 sufficient mouse brains. Using a Nanostring-
based mRNA chip containing 550 microglia-enriched genes20,
154 of these genes were found to be significantly down-regulated
and 41 genes up-regulated in microglia from n-3 deficient mice
whole brains (Fig. 2g, j and Table 1). Among the 40 genes
reported to be unique to homeostatic microglia by20, 20 were
significantly dysregulated, indicating that maternal n-3 PUFA
deficiency alters homeostatic functions of microglia (Fig. 2g). We
next sought to define the diet-specific microglial phenotype by
assessing patterns of gene co-expression using unbiased network
analysis software, Miru21. The utility of identifying gene expres-
sion patterns and transcriptional networks underpinning com-
mon functional pathways in microglia has been previously
described22. Using a Markov clustering algorithm to non-
subjectively subdivide our data into discrete sets of co-expressed
genes, we found three major clusters of genes that were differ-
entially regulated in n-3 deficient mice (Fig. 2i, j). The mean
expression profiles of these three clusters showed that clusters 1
(microglial homeostatic signature) and 2 (fatty acid uptake,
transport and metabolism) contained genes whose expression was
relatively lower in the n-3 deficient group as compared to n-3
sufficient group. In contrast, cluster 3 (innate immune response
and inflammation) contained genes with relatively greater
expression in n-3 deficient mice (Fig. 2j). These results show that
an n-3 PUFA deficient diet dysregulates microglial homeostasis
and increases microglial immune and inflammatory pathways
during development.
Fatty acid changes in microglia, not in synaptic elements,
exacerbate phagocytosis after maternal dietary n-3 PUFA
deficiency. N-3 PUFA deficient diets cause fatty acid alterations
in whole brain tissue23, yet it is unclear to what extent individual
cell types or cell compartments incorporate these changes. To
assess this, we profiled the fatty acid composition of microglia
and synaptosomes isolated from n-3 sufficient and n-3 deficient
mice (Fig. 3a, b). We observed that maternal n-3 PUFA deficiency
significantly altered the fatty acid profile of both microglia and
synaptosomes, with an increase in n-6 fatty acids and a decrease
in n-3 fatty acids (Fig. 3a, b). In particular, DHA was decreased in
microglia from n-3 deficient mice (Fig. 3a), while C22:5n-6 (or
DPA n-6), the n-6-derived structural equivalent of DHA, was
increased as a marker of n-3 PUFA deficiency24 (Fig. 3a). Total
AA was not significantly modified by the diet in microglia
(Fig. 3a), unlike total AA levels in the whole hippocampus
(Supplementary Fig. 4). In synaptosomes, total AA and DPA n-6
levels were significantly increased while total DHA level was
significantly decreased and DPA n-6 inversely increased, as
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Fig. 1 Maternal n-3 PUFA deficiency alters neuronal morphology and function. a Representative images of tertiary apical dendrites (upper panel)
and dendritic arborization (lower panel) of hippocampal CA1 pyramidal neurons from n-3 sufficient and n-3 deficient mice at P21 (Golgi staining).
b Quantification of spine density, total dendritic length and total number of junctions in n-3 deficient and n-3 sufficient animals. For spine counting, n= 12
CA1 pyramidal neurons of the hippocampus, 15–45 segments per animal, 3 mice per group. Means ± SEM. Two-tailed unpaired Student’s t-test, t= 6.396,
***p < 0.0001. For dendritic arborization and total dendritic length, n= 5 neurons from 3 mice for n-3 deficient mice and n= 15 neurons from 4 mice for n-3
sufficient mice. Two-tailed unpaired Student’s t-test; Dendritic length, t= 2.501, *p= 0.0223; number of junctions: t= 1.118, p= 0.28. c Representative
western blots. d Expression of scaffolding proteins in n-3 deficient mice relative to n-3 sufficient mice. Means ± SEM; n= 5–8 mice per group. Two-tailed
unpaired Student’s t-test, t= 0.9986, p= 0.35, SAP102; t= 3.572, **p= 0.0044, cofilin; t= 3.529, **p= 0.0042, PSD95. e Time spent in novel vs familiar
arm in the Y maze task. Means ± SEM; n= 10–17 mice per group. Two-way ANOVA followed by Bonferroni post hoc test: diet effect, F(1,50)= 5.47, p=
0.071; arm effect, F(1,50)= 10.08, p= 0.015; interaction, F(1,50)= 8.08, p= 0.029; familiar vs novel arm for n-3 diet mice: *p < 0.05. Source data are
provided as a Source data file.
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were significantly modified by the diet, such as the saturated fatty
acid (SFA) stearic acid (18:0) and docosanoic acid (C22:0), and
the monounsaturated fatty acids (MUFA) C16:1 n-7, C16:1 n-9,
C18:1 n-9, and C20:1 n-9. Overall, our results show that n-3 and
n-6 PUFA profiles of both microglia and synaptosomes are
altered by low maternal n-3 PUFA intake, displaying similarities
and discrepancies (Fig. 3a, b).
To directly evaluate the effect of microglial and synaptosome
fatty acid alterations on microglial phagocytic activity, we
developed an ex vivo assay in which we exposed freshly isolated
n-3 sufficient or n-3 deficient microglia to n-3 sufficient or n-3
deficient pHrodo-labelled synaptosomes (Fig. 3c). We measured
microglial phagocytic activity based on the level of cellular
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significantly increased in microglia from n-3 deficient mice,
independent of the fatty acid profile of the synaptosome (Fig. 3c).
These data show that both microglial and synaptosome fatty acid
profiles are modified by maternal n-3 PUFA deficiency, but
changes in microglial fatty acid composition drive the exacerba-
tion of microglia-mediated synaptic loss.
Maternal n-3 PUFA deficiency alters neuronal morphology and
working spatial memory in a complement-dependent manner.
Recently, the classical complement cascade has been described
as a key mediator of microglia synaptic refinement in the
developing brain25. Moreover, our EM data revealed more
spine inclusions within microglia and more contacts between
these cells and the synaptic cleft (Fig. 2a, b). Thus, we explored
the implication of the complement cascade in the exacerbation
of microglia-mediated synaptic refinement observed in n-3
deficient mice.
The complement system acts as a recognition mechanism by
which C1q, the initiating protein of the cascade, tags synapses to
be removed. C1q-tagging leads to the cleavage of C3 and
subsequent deposition of C3a and C3b, which activates CD11b
and C3aR respectively on microglia and triggers synaptic
elimination by microglial phagocytosis25,26. C1q immunostaining
was significantly increased in both the hippocampus CA1 and DG
in n-3 deficient mice (Fig. 4a). Protein expression levels of CD11b
(a subunit of CR3) was slightly, yet significantly increased in the
DG in n-3 deficient mice (Fig. 4b). CD11b gene expression was
also enhanced in the whole hippocampus in these mice
(Supplementary Fig. 5). Our analyses also revealed a robust
increase of C3aR immunostaining in the whole hippocampus of
n-3 deficient mice, corroborating microglia transcriptomic data
(Figs. 4c and 2g and Table 1). The C3aR-positive cells were
uniformly distributed throughout the hippocampus, including the
CA1. Expression levels of Cx3cr1, Cx3cl1 and Tgfb, all involved in
microglia-mediated synaptic pruning13,27, were found to be
increased in the whole hippocampus of n-3 deficient mice
(Supplementary Fig. 5). Finally, we quantified the C3 protein on
freshly extracted hippocampus synaptosomes from n-3 deficient
and n-3 sufficient mice using an ELISA assay. We found higher
amounts of C3 under n-3 PUFA deficiency (Fig. 4D). These
findings indicate that low n-3 PUFA intake alters the develop-
mental expression of complement cascade proteins both in
microglia and at the synapse.
To test whether proper neuronal function could be restored by
acting on the complement pathway in vivo, we antagonized CR3
activation in n-3 deficient mice. We first confirmed that a CR3
antagonist XVA-143, blocked n-6 PUFA (AA) induced increases
in phagocytosis in vitro (Supplementary Fig. 6A–D). We then
administered the CR3 antagonist, XVA-14328 in vivo in the
hippocampus four days before assessing the expression of the
post-synaptic protein PSD95 at P21. Antagonizing CR3 prevented
PSD-95 expression decrease in the hippocampus of n-3 deficient
mice (Fig. 4e). Injection of XVA-143 also restored optimal
memory abilities in n-3 deficient mice in the Y-maze task
(Fig. 4f). These results show that complement activation increases
microglia-mediated synaptic refinement when dietary n-3 PUFAs
are low. Thus, a global increase in C3/CR3 interaction may
account for the altered neuronal function observed in the
hippocampus of n-3 deficient mice.
Enhancement of microglia-mediated synaptic refinement by
maternal PUFA deficiency is phosphatidyl serine recognition-
independent. Microglia possess a number of phagocytic
receptors to eliminate neuronal elements, notably by binding to
externalized phosphatidyl serine (PS) at the surface of neu-
rons29. Since PUFAs are the main constituents of membrane
phospholipids, we assessed whether microglial phagocytic
activity was enhanced through PS recognition (Supplementary
Fig. 7). First, we showed that cell-surface PS, stained with
Fig. 2 Maternal n-3 PUFA deficiency increases microglial phagocytosis and gene expression profile. a, b Representative images (a) and quantification
(b) of EM data from the CA1 region of n-3 sufficient and n-3 deficient mice. s spine, m microglial processes, t terminals, * extracellular debris, ma
myelinated axons. Arrowheads point to synaptic clefts. Scale bars= 1 μm. Two-tailed unpaired Student’s t-test; t= 5.24, **p= 0.0063, cleft; t= 3.366,
*p= 0.0282, spine inclusions; t= 2.601, p= 0.06, cellular inclusions; t= 2.119, p= 0.1015, extracellular digestion. c Three-dimensional reconstructions of
PSD95-immunoreactivity (red) outside (arrowheads) or colocalized with (arrows) microglial cells (green). d Quantification of PSD95 and Iba1
immunoreactivity colocalization in the CA1 region of n-3 deficient and n-3 sufficient group. Means ± SEM; n= 4–6 mice per group. Two-tailed unpaired
Student’s t-test; t= 2.583, *p= 0.032. e Representative bivariate dot plots of isolated microglial cells gated on CD11b+/CD45low expression from n-3
sufficient and n-3 deficient mice. f FACS analysis of phagocytic uptake of pHrodo-labeled E. Coli bioparticles by CD11b+ microglial cells from both dietary
groups after 180min of incubation (expressed as the percent of cells that are CD11b+ and PE positive). Means ± SEM; n= 3–4 per condition. Two-way
ANOVA; diet effect: F(1, 20)= 5.628, *p= 0.028; time effect, F(3,20)= 10.04, p= 0.0003; Interaction, F(3,20)= 0.1771, p= 0.91. The area under the
curve is presented as an independent graph in c. Two-tailed unpaired Student’s t-test, t= 1.289, p= 0.25. g Heatmap of significantly up or downregulated
genes in each dietary group. Each lane represents one animal (n= 4 or 6 per group). The 20 homeostatic microglia unique genes that were significantly
affected by the diet are labelled. h Number of microglial genes that are up-regulated, down-regulated or not regulated by the diet. i A transcript-to-
transcript correlation network graph of transcripts significantly differentially expressed by diet groups was generated in Miru (Pearson correlation threshold
r≥ 0.85). Nodes represent transcripts (probe sets), and edges represent the degree of correlation in expression between them. The network graph was
clustered using a Markov clustering algorithm, and transcripts were assigned a color according to cluster membership. j Mean expression profile of all
transcripts within clusters 1, 2, and 3 where each point represents an animal and the average gene expression of all genes within that cluster for that animal.
Source data are provided as a Source data file.









aFor detailed composition, see Table 2.
bComposition (g/kg): sucrose, 110.7; CaCO3, 240; K2HPO4, 215; CaHPO4, 215; MgSO4,7H2O,
100; NaCl, 60; MgO, 40; FeSO4,7H2O, 8; ZnSO4,7H2O, 7; MnSO4,H2O, 2; CuSO4,5H2O, 1;
Na2SiO7,3H2O, 0.5; AlK(SO4)2,12H2O, 0.2; K2CrO4, 0.15; NaF, 0.1; NiSO4,6H2O, 0.1; H2BO3, O.1;
CoSO4,7H2O, 0.05; KIO3, 0.04; (NH4)6Mo7O24,4H2O, 0.02; LiCl, 0.015; Na2SeO3, 0.015;
NH4VO3, 0.01.
cComposition (g/kg): sucrose, 549.45; retinyl acetate, 1; cholecalciferol, 0.25; DL-α-tocopheryl
acetate, 20; phylloquinone, 0.1; thiamin HCl, 1; riboflavin, 1; nicotinic acid, 5; calcium
pantothenate, 2.5; pyridoxine HCl, 1; biotin, 1; folic acid, 0.2; cyanobalamin, 2.5; choline HCl,
200; DL-methionin, 200; p-aminobenzoic acid, 5; inositol, 10.
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annexin-V, was unchanged between diets in the hippocampus
(Supplementary Fig. 7A). We also quantified the expression
levels of the microglial PS-binding protein milk fat globule
EGF factor 8 (MFG-E8), which binds and activates a vitro-
nectin receptor (VNR), TAM receptor tyrosine kinases (MER
and Axl), triggering receptor expressed on myeloid cells-2
(TREM2) and CD3329,30. Only MFG-E8 expression level was
significantly increased by maternal n-3 PUFA dietary defi-
ciency (Supplementary Fig. 7B–G). We administered a block-
ing peptide cRGD which inhibits the interaction between
Total fatty acids composition of microglia
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MFG-E8 and VNR vs a scrambled control (sc-cRGD), to n-3
deficient vs n-3 sufficient mice animals and quantified the
expression of the post-synaptic protein PSD-95. Blocking
MFG-E8 action on microglia did not prevent the reduction in
PSD-95 expression in the hippocampus of n-3 deficient mice
(Supplementary Fig. 7H). These results indicate that modula-
tion of the microglial phagocytic capacity by early-life PUFAs
is PS recognition-independent.
Fig. 3 Maternal dietary n-3 PUFA deficiency exacerbates microglial phagocytosis of synaptic elements by predominantly impacting microglia. a Fatty
acid composition of microglial cells sorted from n-3 sufficient and n-3 deficient mice. Means ± SEM; n= 4 mice per group. Insert: higher magnification of
low expressed fatty acids. Two-tailed unpaired Student’s t-test; t= 3.37, *p= 0.015, C10:0; t= 4.852, **p= 0.0028, C12:0; t= 2.473, *p= 0.0482, C14:1
n-7; t= 9.646, ***p < 0.0001, DPA n-6; t= 2.558, *p= 0.043, ALA; t= 2.972, *p= 0.0249, DHA; nd not detected. b Fatty acid composition of
synaptosomes sorted from n-3 sufficient and n-3 deficient mice. Means ± SEM; n= 4 mice per group. Insert: higher magnification of low expressed fatty
acids. Two-tailed unpaired Student’s t-test; t= 2.82, *p= 0.047, C17:0; t= 3.05, *p= 0.038, C18:0; t= 5.05, **p= 0.0072 C18:1 n-9; t= 2.99, *p= 0.04,
C18:2 n-6; t= 26, ***p < 0.0001, C20:2 n-6; t= 3.57, *p= 0.023, C22:4 n-6; t= 12.68, ***p= 0.0002, DPA n-6; t= 4.49, *p= 0.011, C20:5 n-3; t= 7.12,
**p= 0.0021, DHA; nd not detected. c FACS analysis of phagocytic uptake of pHrodo-labeled synaptosomes (sorted from n-3 sufficient or n-3 deficient
mice) by CD11b+ microglial cells (sorted from n-3 sufficient or n-3 deficient mice). Analyses were performed 2 h post-synaptosomes application. On FACS
plots: x-axis= (pHrodo intensity (PE intensity), y-axis= SSC. Means ± SEM; n= 8 per condition. Two-way ANOVA: microglial fatty acid status effect,
F(1,28)= 19.77, ***p= 0.0001; synaptosomes fatty acid status effect, F(1,28)= 1.63, p= 0.2123; interaction, F(1,28)= 0.2826, p= 0.599. Source data are
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Fig. 4 Maternal n-3 PUFA deficiency exacerbates microglia-mediated shaping of neuronal networks in a complement-dependent manner.
a–c Representative images and quantification of C1q, CD11b, and C3aR immunostaining in coronal sections of n-3 deficient and n-3 sufficient mice
hippocampus. Scale bar= 100 μm. Means ± SEM; n= 3–13 mice per group. Two-tailed unpaired Student’s t-test; t= 1.553, p= 0.135, CD11b CA1; t= 2.114,
*p= 0.466, CD11b DG; t= 0.5495, *p= 0.0223 C1q CA1; t= 3.938, **p= 0.0056, C1q DG; t= 4.91, **p= 0.0027, C3aR, total hippocampus. d Protein
quantification (ELISA) reveals that synaptosomes from n-3 deficient mice express more C3 than n-3 sufficient animals. Means ± SEM; n= 7–8 mice per
group; Two-tailed unpaired Student’s t-test; t= 2.097, p= 0.0562. e Quantification of PSD95 protein expression in n-3 sufficient vs n-3 deficient mice
treated with XVA-143 or its vehicle. Means ± SEM; n= 5–8. Two-way ANOVA followed by Bonferroni post hoc test: diet effect, F(1,21)= 11.89, p= 0.0024;
treatment effect, F(1,21)= 0.1436, p= 0.708; interaction, F(1,21)= 5.977, p= 0.0234; n-3 sufficient vs n-3 deficient, **p < 0.01. f Time spent in novel vs
familiar arm in the Y maze task in n-3 sufficient vs n-3 deficient mice treated with XVA-143 or its vehicle. Means ± SEM; n= 9–10 mice per group. Paired
t-test: n-3 sufficient group, **p= 0.0019; n-3 deficient group, p= 0.357; n-3 sufficient+ XVA-143 group, **p= 0.0013; n-3 deficient+ XVA-143 group,
**p= 0.0099. Source data are provided as a Source data file.
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Maternal n-3 PUFA deficiency alters microglial PUFA meta-
bolism in the offspring. Our data suggest that n-3 PUFA
deficiency specifically drives exacerbated microglial phagocy-
tosis (Fig. 3). We, therefore, assessed the mechanisms by which
microglial PUFA metabolism was driving their phagocytic
activity. Microglia isolated from n-3 deficient mice had higher
levels of free, unesterified, AA, and lower quantities of free
EPA, as determined by high-performance liquid chromato-
graphy with tandem mass spectrometry (LC-MS-MS) (Fig. 5a).
When unesterified from the cellular membrane, free PUFAs are
rapidly converted to bioactive mediators (or oxylipins) with
potential effects on microglial cells1,31,32. Interestingly,
microglia from n-3 deficient animals presented greater levels of
AA-derived bioactive mediators and lower amounts of DHA-
and EPA-derived mediators (Fig. 5b). Four AA-derived oxyli-
pins were significantly increased by maternal n-3 PUFA defi-
ciency: trioxilins TRXA3 and TRXB3, 8-HETE, 12-HETE,
while three EPA-derived species were significantly decreased:
+/−11-HEPE, 15S-HEPE, and LTB5. The DHA-derived
17SHDoHE was also reduced (p= 0.0957) (Fig. 5c). Hence,
we show the post-natal microglia oxylipin signature in the
context of low maternal n-3 PUFA intake and how it is mod-
ified by the dietary content in n-3 PUFAs.
Activation of a 12/15-LOX/12-HETE signaling pathway
increases microglial phagocytic activity under maternal n-3
PUFA deficiency. Using pharmacological approaches, we con-
tinued to dissect the molecular mechanisms linking n-3 PUFA
deficiency and microglial phagocytosis of dendritic spines by
assessing the oxylipins identified above. We first tested the
potential role of AA, EPA, and DHA free forms and their
bioactive metabolites identified in Fig. 5 (except trioxilins TRXA3
and TRXB3, which are not commercially available) on microglial
phagocytosis in vitro. We applied synaptosomes that were con-
jugated to a pH-sensitive dye (pHrodo), as a surrogate of synaptic
refinement processes on cultured microglia (Fig. 6a). Twenty-
four-hour application of AA on microglial cells significantly
increased their phagocytic activity towards synaptosomes
(Fig. 6b). These observations confirmed our data showing that
AA increased phagocytosis of latex beads by primary microglial
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Fig. 5 Maternal n-3 PUFA deficiency alters fatty acid profile in microglia. a Quantification of free (unesterified) forms of AA, EPA, and DHA levels in
microglia. Means ± SEM; n= 4 mice per group. Two-tailed unpaired Student’s t-test; t= 3, *p= 0.024, free AA; t= 6.12, ***p= 0.0009, free EPA; t=
1.149, p= 0.2942, free DHA. b Heat map of all AA-, EPA-, and DHA-derived intracellular mediators expressed by microglia. c AA- EPA- and DHA-derived
mediators that are significantly modulated by early-life n-3 PUFA deficient diet. Means ± SEM; n= 4 mice per group. Two-tailed unpaired Student’s t-test;
t= 2.693, *p= 0.0359, TRXA3; t= 2.867, *p= 0.0286, TRXB3; t= 3.028, *p= 0.0231, 8-HETE; t= 2.886, *p= 0.0278, 12-HETE; t= 3.656, *p= 0.0106,
+/−11-HEPE; t= 3, *p= 0.024, 15S-HEPE; t= 3, *p= 0.024, LTB5; t= 1.975, p= 0.0957, 17S-HDoHE. Source data are provided as a Source data file.
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DHA significantly decreased phagocytosis (Fig. 6b), while EPA
and DPA n-6 had no effect when compared to controls (Fig. 6b).
Then, we applied PUFA bioactive mediators for 30 min before
applying pHrodo synaptosomes and studied the kinetics of pha-
gocytosis over the following 120 min. We show that the AA-
derived 12-HETE significantly increased microglia phagocytosis
of synaptosomes while 8-HETE had no effect (Fig. 6c). None of
the EPA- and DHA-derived bioactive mediators affected primary
microglia phagocytic activity (Fig. 6d). For all conditions, the
percentage of phagocytic cells is significantly higher at 120 min
post-treatment (Fig. 6c, d).
AA is metabolized into 12-HETE via the 12/15-LOX enzyme
and its activity is blocked by baicalein, which reduces 12-HETE
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activity was able to restore normal phagocytic activity in n-3
PUFA deficient microglial cells. We used an ex vivo assay in
which we exposed freshly sorted n-3 sufficient or n-3 deficient
microglia to pHrodo synaptosomes with or without the 12/15-
LOX inhibitor baicalein (Fig. 6e). We show that baicalein
significantly reduced synaptosome phagocytosis by n-3 deficient
microglia (Fig. 6f). Injection of baicalein persistently restored
optimal memory abilities in n-3 deficient mice in the Y-maze task
(Fig. 6g), without altering anxiety level (Supplementary Fig. 8A).
Baicaelin had no effect in n-3 sufficient mice (Supplementary
Fig. 8B). These results confirm that the 12/15-LOX/12-HETE
pathway is active in n-3 deficient microglia to increase their
phagocytic activity towards synaptic elements. In addition,
baicalein improves memory deficits in n-3 PUFA deficient mice.
The 12/15-LOX/12-HETE signaling pathway acts upstream of
the complement cascade. We finally assessed the relationship
between 12/15-LOX/12-HETE signaling pathway and the
expression of genes from the complement cascade under n-3
PUFA deficiency. We exposed freshly sorted n-3 sufficient or n-3
deficient microglia to the 12/15-LOX inhibitor baicalein or its
vehicle and quantified the expression level of CD11b and C3aR
mRNAs, 2 h later (Fig. 7a). We show that c3ar gene expression
was increased in n-3 deficient microglia while the expression of
cd11b was not significantly modulated by the diet. This is in line
with our immunostaining experiments in which CD11b was
moderately increased under n-3 PUFA deficiency, only in the DG,
while C3aR was robustly increased in the whole hippocampus
(Fig. 4b). Baicalein significantly reduced C3aR expression in n-3
deficient microglia, while it had no effect on CD11b (Fig. 7b, c).
These results suggest that in non-stimulated n-3 deficient
microglia, the 12/15-LOX/12-HETE signaling pathway is impli-
cated in the maintenance of a high C3aR tone, while the activity
of CD11b (as shown in Fig. 4e, f) is likely to depend on other
mechanisms.
Once activated, the expression of most immune receptors is
dampened as part of a global regulatory mechanism35. We thus
examined the relationship between the 12/15-LOX/12-HETE
signaling pathway and the complement cascade in the condition
of stimulation of microglia with synaptosomes. We exposed
freshly sorted cells to pHrodo synaptosomes in the presence of
baicalein or its vehicle and quantified the expression level of
cd11b and c3ar (Fig. 7d). The expression level of CD11b was
significantly increased by baicalein in n-3 deficient microglia,
whereas inhibiting the 12/15 LOX enzyme did not affect C3aR
mRNA expression (Fig. 7e, f). This suggests that once microglia
phagocyte synaptosomes, the 12/15-LOX/12-HETE signaling
pathway inhibits CD11b expression while allowing phagocytosis
of neuronal material (Fig. 6f). We finally studied the expression
levels of BLT2 and GPR31, the two principal 12-HETE receptors
(Supplementary Fig. 9A). While GPR31 was expressed by the
cells, BLT2 gene expression was almost not measurable in
microglia in vitro. Hence, we then focused on the expression of
GPR31 in vivo, on freshly isolated n-3 deficient and n-3 sufficient
microglia, treated with vehicle or baicalein, in the absence or
presence of synaptosomes. We could not find any significant
modification of GPR31 mRNA expression level in any of the
conditions tested (Supplementary Fig. 9B, C). Further experi-
ments are needed to decipher whether 12 HETE effect on
phagocytosis is mediated by GPR31.
Altogether, our data suggest that the 12/15-LOX/12-HETE
signaling pathway modulates microglial phagocytosis under n-3
PUFA deficiency, partly by regulating the expression of the C3a
and C3b receptors.
Discussion
The phagocytic activity of microglia during development is cru-
cial in shaping neuronal networks, and dysfunction of this activity
contributes to neurodevelopmental disorders15. Here we show
that low maternal n-3 PUFA intake-induced modification of
microglia fatty acid composition is a potent driver leading to
exacerbation of spine phagocytosis in the offspring. This process
is complement-dependent, a mechanism that has been repeatedly
reported to be the molecular bridge of microglia phagocytosis of
spines14,27,36. Our data also reveal that n-3 PUFA deficiency
alters the shaping of hippocampal neurons and spatial working
memory in pups. Finally, we identified a previously unknown
function of 12-HETE, a LOX metabolite of AA, in the regulation
of microglial phagocytosis. This microglial 12/15-LOX/12-HETE
pathway is also likely to contribute to alterations in spine density
and connectivity observed in synaptopathies and neurodevelop-
mental disorders37. Considering that n-3 PUFAs also determine
the offspring’s microglia homeostatic molecular signature and
fatty acid profile, our study suggests that the maternal nutritional
environment is essential for proper microglial activity in the
developing brain. These findings further support the importance
of dietary n-3 PUFAs in the neurodevelopmental trajectory,
pointing to their role in microglia-spine interactions.
Previous clinical and epidemiological studies revealed a rela-
tionship between dietary n-3 PUFA content, brain development,
and the prevalence of neurodevelopmental disorders38. The n-3
PUFA index, which reports the level of n-3 PUFAs (EPA+DHA)
in erythrocytes and that is used as a biomarker for cardiovascular
diseases, is now also considered a biomarker for several neuro-
development diseases such as ASD39, attention deficit hyper-
activity disorder (ADHD)40 and schizophrenia41. The lack of n-3
PUFA during pregnancy and early post-natal life could partici-
pate in the etiology of these diseases. Since these essential fatty
acids are necessary for healthy brain development, low dietary
supply or impairment of their metabolism is suggested to be
Fig. 6 Maternal n-3 PUFA deficiency exacerbates microglial phagocytic activity towards synapses by activating the 12/15-LOX/12-HETE signaling
pathway. a Experimental setup. b FACS analysis of phagocytic uptake of pHrodo-labeled synaptosomes by CD11b+ microglial cells in primary culture
exposed to PUFAs. Means ± SEM; n= 5–6 per condition. Two-tailed unpaired Student’s t-test; ***p= 0.0005, AA; *p= 0.0118, DHA; p= 0.55, EPA; p=
0.153; DPA n-6. c, d FACS analysis of phagocytic uptake of pHrodo-labeled synaptosomes by CD11b+ microglial cells in primary culture exposed to n-6 AA-
derived (c) or n-3 EPA- and DHA-derived (d) lipids. Means ± SEM; n= 6–14 per condition. AA derivatives: Two-way ANOVA: time effect, F(1,33)= 171.8,
***p < 0.0001; treatment effect, F(2,33)= 5.538, **p= 0.0084; interaction, F(2,33)= 0.686, p= 0.51. EPA and DHA derivatives: Two-way ANOVA: time
effect, F(1,64)=57.25 ***p < 0.0001; treatment effect, F(2,64)= 1.462, p= 0.239; interaction, F(2,64)= 1.904, p= 0.157. e Experimental setup. f FACS
analysis of phagocytic uptake of pHrodo-labeled synaptosomes by freshly sorted n-3 deficient and n-3 sufficient CD11b+ microglial cells, exposed to
baicalein or its solvent. Analyses were performed 2 h post-synaptosomes application. Two-way ANOVA: microglia fatty acid status effect, F(1,51)= 12.6
***p= 0.0008; treatment effect, F(1,51)= 16.06, p= 0.0002; interaction, F(1,51)= 0.1912, p= 0.6638. g Time spent in novel vs familiar arm in the Y maze
task in P21 and P30 n-3 deficient mice treated with baicalein or its vehicle. Means ± SEM; n= 10 (P21) or 5 (P30) mice per group. Paired t-test: P21: n-3
deficient group, p= 0.5; n-3 deficient+ baicalein group, p= 0.11; P30: n-3 deficient group, p= 0.57; n-3 deficient+ baicalein group, *p= 0.029. Source
data are provided as a Source data file.
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involved in the etiology of several psychiatric diseases, including
neurodevelopmental disorders1. Indeed, decreased DHA levels
have been reported in several brain regions of patients diagnosed
with such disorders42. Low n-3 PUFA index is also associated
with reduced brain size or connectivity, as well as to reduced
cortical functional connectivity during an attentional task43. Of
special interest is the limbic system as the hippocampus activity in
Humans has been reported to be altered in subjects with low n-3
PUFA status and consistently altered in animal models of n-3
PUFA deficiency44,45. Hippocampal alterations are reported in
several neurodevelopmental disorders, including ASD, that could
account for a neurodevelopmental compensatory mechanism to
preserve cognitive domains46. Preterm infants display lower brain
DHA concentrations as compared to term infants on the same
ALA fortified diet47. Very low birth weight is a high-risk factor
for both n-3 PUFA deficiency and neurodevelopmental disorders/
cognitive impairments48. These children display improved
recognition memory at 6-months of age when supplemented with
LC n-3 PUFA49 while the brain structure was unchanged later in
life (8 years old)50. Whether the pathophysiology of cognitive
alterations, a common feature of neurodevelopmental disorders,
may be linked to inadequate bioavailability of n-3 PUFA in the
hippocampus is of high interest in part due to the increasing
knowledge on the role of nutrition in psychiatric disorders and in
particular ASD, ADHD and schizophrenia.
Overall, this knowledge suggests the use of specific dietary
supplementation with n-3 PUFA as an environmental modifiable
factor. Indeed, dietary supplementation or increase intake of food
rich in n-3 PUFA could counteract the adverse effect of low n-3
PUFA intake. Our data shed light on an oxylipin-dependent
mechanism underlying these clinical observations.
Our data are in line with previous studies showing that the 12/
15-LOX/12-HETE pathway is altered in several pathological
conditions in macrophage/microglia and especially in inflam-
matory conditions. Human macrophages incubated with 12-
HETE showed induced gene expression after lipopolysaccharide
(LPS) application51. Indeed, 12-HETE in macrophages was
shown to activate extracellular signal-regulated kinase 1/2 (ERK1/
2) and nuclear factor kappa-light-chain-enhancer of activated B
cells (NFκB) via GPR3152. In humans, it was found that the
expression of 12/15-LOX was increased in CD68-positive acti-
vated microglia53. Moreover, 12/15-LOX and Gpr31 receptor
gene expression is increased in microglia along with aging22 and
in DAM/MGnD54. Here, no change in gpr31 gene expression was
observed in microglia treated with 12-HETE in vitro or exposed
to a n-3 PUFA deficient diet in vivo. However, downstream
analysis of GPR31 activation after 12-HETE application or
expression should be tested.
Previous studies conducted in rodents and primates showed
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Fig. 7 The 12/15-LOX/12-HETE signaling pathway controls gene expression of the complement pathway. a Experimental setup. b, c Quantification of
cd11b and c3ar mRNA expression in freshly sorted n-3 deficient and n-3 sufficient microglia, treated with baicalein or its vehicle. Means ± SEM; n= 4–6 per
group. Two-way ANOVA: cd11b: diet effect, F(1,15)= 0.57, p= 0.46; treatment effect, F(1,15)= 1.37, p= 0.26; interaction, F(1,15)= 2.48, p= 0.14;
c3ar: diet effect, F(1,18)= 1.36, p= 0.26; treatment effect, F(1,18)= 1.52, p= 0.23; interaction, F(1,18)= 4.36, *p= 0.051. d Experimental setup.
e, f Quantification of cd11b and c3ar mRNA expression in freshly sorted n-3 deficient and n-3 sufficient microglia, exposed to synaptosomes for 2 h
and treated with baicalein or its vehicle. Means ± SEM; n= 8 per group. Two-way ANOVA followed by Bonferroni post hoc test: cd11b: diet effect, F(1,28)=
0.16, p= 0.19; treatment effect, F(1,28)= 0.92, **p= 0.0028; interaction, F(1,28)= 0.072, p= 0.36; n-3 deficient+ vehicle vs n-3 deficient+ baicalein,
*p= 0.014; n-3 deficient+ vehicle vs n-3 deficient+ baicalein, *p= 0.029; c3ar: diet effect, F(1,28)= 0.35, **p= 0.0034; treatment effect, F(1,28)=
0.0043, p= 0.72; interaction, F(1,28)= 0.0019, p= 0.81. Source data are provided as a Source data file.
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memory in adulthood55,56. Here, we show that perinatal n-3
PUFA deficiency-induced memory deficits occur as soon as
weaning. This corroborates observations in humans that prenatal
and cord blood n-3 PUFA levels are positively correlated with
later-life cognitive abilities in infants57. In our study, cognitive
alterations were associated with a decrease in dendritic length,
whereas the complexity of dendritic arborization was unchanged,
supporting the previous reports58. A significant decrease of post-
synaptic scaffold proteins PSD-95 and Cofilin in the hippo-
campus of n-3 deficient mice at weaning, suggests an early
alteration of synaptic plasticity(Madore et al., 2014). This is in
line with a previous study showing that loss of PSD-95 is inversely
correlated with DHA dietary supply in a mouse model of Alz-
heimer’s disease59 suggesting that PSD-95 expression depends on
DHA levels in a broader context than just neurodevelopment. N-
3 PUFA deficiency-mediated dendritic arborization alteration has
been associated with functional defects of neuronal networks in
the adult hippocampus and cortex60,61 and atypical whole-brain
functional community structure62, a surrogate of cognitive defi-
cits63. Finally, our finding of abnormal hippocampal neuronal
spine density in n-3 PUFA deficient mice at weaning corroborates
data previously found58.
Lipid changes driving metabolic alterations in microglia and
their impact on phagocytosis in the developing brain are under-
studied. Knowing that microglia are now regarded as key con-
trollers of synaptic architecture due to their phagocytic
activity13,14,16, we show that specific fatty acid mediators drive
microglia phagocytic activity toward synapses. Our findings of a
decrease in n-3 PUFAs and increase in n-6 PUFAs in the whole
hippocampus, microglia, and synaptosomes of n-3 deficient mice
is consistent with a large body of literature24,64. It is well estab-
lished that in response to n-3 PUFA deficiency, brain DHA
decreases and is replaced by DPA n-624,64. We have previously
shown that microglia from n-3 deficient dams have higher levels
of DPA n-665. While the mechanisms of this replacement at the
level of the microglia are not clear, in whole brain, the uptake of
DPA n-6 from the plasma free pool increases dramatically66.
Oxylipins are involved in the regulation of inflammation and
phagocytic activity of immune cells1. Their production is largely
influenced by n-3 PUFA dietary supply, including in the brain32.
Using LC-MS-MS, we examined their role in microglial phago-
cytic activity during development. We show that n-3 PUFA
deficient microglia have a unique oxylipin profile, linked to
altered free forms of AA, EPA, and DHA. AA and its LOX-
derived mediator 12-HETE promote microglia phagocytosis of
synaptosomes. While there is no data available in the literature on
microglia, this pathway has already been described as essential in
the clearance of apoptotic cells by peripheral macrophages during
inflammation67. Therefore, we predict that the 12/15-LOX
enzyme is involved in AA-mediated increase in microglia pha-
gocytosis in vitro. Conversely, DHA (but not its LOX derivative,
17S-HDOHE) decreased microglial phagocytosis in vitro. Pre-
vious work reported that DHA inhibits microglia phagocytic
activity of myelin both in vivo and in vitro68 and normalizes
inflammation-induced microglial phagocytic activity of spines
in vitro69. Hence, it is likely that DHA dampens microglial
phagocytosis via a repressive effect on synaptosome phagocytosis
and/or a decrease in pro-inflammatory factors expression, in
accordance with previous work showing its anti-inflammatory
activity both in vitro and in vivo70–73. Additionally, recent work
found that DHA decreases microglia phagocytic activity of myelin
debris in the spinal cord after injury through mir-12468, a non-
coding nucleotide involved in synaptic plasticity. In macrophages,
mir-124 has been shown to regulate actin-related protein 2/3
(ARP2/3), which is involved in the formation of the phagocytic
cup74. This is in line with results showing that DHA reduced LPS-
induced phagocytic activity of microglia, through a reduction of
filopodia75.
12-HETE is produced by the 12/15 LOX enzyme and conver-
sion of AA by 12-HETE is enhanced in n-3 PUFA deficient
microglia in the context of brain injury, autoimmune and neu-
rodegenerative diseases53. 12/15 LOX is also expressed in the
developing human brain by CD68-positive microglia and oligo-
dendrocytes53. We show that blocking activity of 12/15-LOX by
baicalein34 attenuates the excessive n-3 PUFA deficient microglia
phagocytic activity, which is coherent with the role of this enzyme
in mediating phagocytic activity of apoptotic cells by macro-
phages67. Hence, we describe a cell-specific fatty acid profile of
microglia and provide a comprehensive description of the pro-
cesses involved in n-3 PUFA deficiency-induced microglial
alterations, including 12/15-LOX/12-HETE pathway as the
molecular trigger enhancing the phagocytic activity of microglia
toward spines.
We further deciphered the relationship between the 12/15-
LOX/12-HETE pathway and the complement system. Our data
reveal that the phagocytic capacity of microglia is increased only
when the cells are n-3 deficient, even though C3 is overexpressed
on n-3 deficient synaptosomes. These data suggest that both
opsonization of synapses and recognition of C3 by its microglial
receptors are required to trigger phagocytosis. This confirms a
plethora of reports on the complement-dependent phagocytosis
in the immune system. It is already well described that there is
little to no ingestion of opsonized elements without phagocyte
activation76. Conversely, CR3-mediated phagocytosis is depen-
dent on receptor conformational changes, lateral diffusion, and
clustering, processes that require activating stimuli77). Hence,
binding of C3 to the complement receptors can be considered as
the recognition (“find-me”) mechanism of spines to be removed
by microglia, as previously shown in other experimental
contexts14,78, while activation of the 12/15-LOX/12-HETE path-
way is the triggering signal for phagocytosis by microglia. This is
coherent with the observation that the complement cascade
classically interacts with inflammatory pathways to control the
activity of phagocytes79.
Interestingly, C3a, that binds to microglial C3aR, is usually
considered as a chemoattractant signal, attracting immune cells
including microglia toward the structures to be cleared, while
C3b, that binds to CR3 (CD11b+ CD18) opsonizes the target to
be removed79. Our data show that the 12/15-LOX/12-HETE
pathway controls the basal expression of C3aR in n-3 deficient
microglia, suggesting that it may control the capacity of microglia
to reach the target. However, the 12/15-LOX/12-HETE pathway
does not regulate the gene expression of CD11b, which is in line
with the observations that CD11b activation is more dependent
on conformational changes and redistribution in the cellular
membrane rather than on transcriptional regulation77. As for
CD11b activity, our data suggest that the 12/15-LOX/12-HETE
pathway is involved in the homeostatic down-regulation of
CD11b expression once the opsonized elements have been
recognized by microglia. Overall, our data suggest that the 12/15-
LOX/12-HETE pathway is activated upstream of the complement
cascade, controlling the gene expression level and activity of this
latter. We also found that 12/15-LOX/12-HETE pathway mod-
ulates microglial phagocytic activity as baicalein reduces synap-
tosomes engulfment. More experiments should be conducted to
decipher the interplay of 12/15-LOX/12-HETE and the comple-
ment pathways in the phagocytic activity of n-3 deficient
microglia.
Deficits in microglia-mediated synaptic refinement lead to
dysfunctional neuronal networks and behavioral abnormalities
resembling some aspects of neurodevelopmental disorders15,80,81.
Here, we show that n-3 PUFA deficient microglia display an
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altered homeostatic molecular profile at weaning with features
similar to neurodegenerative microglia, previously reported as
more phagocytic54. We further identified the complement system,
and not PS exposure, as the molecular mechanism driving spine
phagocytic activity upon n-3 PUFA deficiency. This is consistent
with previous work showing that in the hippocampus, PS-
dependent and complement-independent trogocytosis of pre-
synaptic elements remodels neuronal network during normal
brain development82,83 while complement-dependent phagocy-
tosis of synapses is promoted in models of brain diseases
presenting neuronal network abnormalities, including neurode-
velopmental disorders13,14,38. Of note, neither PS recognition nor
the complement cascade seem to be involved in synaptic refine-
ment in n-3 sufficient mice. This suggests that (1) other
mechanisms of microglia-mediated synaptic refinement are in
place in the hippocampus of these animals or (2) microglia-
mediated synaptic refinement is not prominent in the hippo-
campus of these animals. Microglia use a plethora of recognition
mechanisms for phagocytosis of neuronal elements/dead bod-
ies33,84 but few studies have addressed the microglia-spine
interaction in the developing hippocampus. On the other hand,
several mechanisms, including microglia-independent processes
such as neuronal macroautophagy or phagocytosis by astrocytes,
control synaptic pruning in the developing brain, though the
proportion of synaptic pruning relying on microglia in the
developing hippocampus is not known85. Our data suggest that
synaptic pruning mechanisms in the developing hippocampus of
n-3 sufficient mice may favor microglia-independent processes.
Overall, our data also describe a role for the 12/15-LOX/12-
HETE oxylipin pathway as a crucial metabolic signaling axis in
the regulation of n-3 PUFA deficient microglia activity. We also
delineate that maternal dietary n-3 PUFA deficiency drives
microglia in the offspring into a complement-dependent phago-
cytic phenotype, aberrantly reducing synaptic elements, which
drive hippocampal synaptic network dysfunction and spatial
working memory deficit. Our findings not only support the
necessity of adequate n-3 PUFA status during brain develop-
ment86, but also reveal that maternal lipid nutrition, by mod-
ulating microglial fatty acid metabolism and sensing, can be an
important determinant of neurodevelopmental synaptopathies
such as ASD. Regarding the clinical implications, these data
highlight the relevance of diagnosing DHA/EPA deficits in
expectant mothers and in early-life. We provide knowledge on
highly targetable cellular and molecular pathways linking
maternal nutrition and neurodevelopmental disorders. Indeed,
specific dietary strategies can enhance PUFA status in micro-
glia65, being promising avenues for the prevention and treatment
of neurodevelopmental disorders.
Methods
Animal experiments were carried out according to the Quality Reference System of
INRA and approved by the local ethical committee for care and use of animals
(#APAFIS 4198and 15533). Male and female CD1 mice 8-week old were purchased
from Janvier Labs (Le Gesnest St Isle, France) and were SPF-housed in temperature
and humidity-controlled cages on a 12 h light/dark cycle with food and water ad
libitum. The use of CD1 mice, an outbred strain, implies intrinsic inter-individual
differences which we consider as an asset, considering the translational perspective
of our research.
Diet. After mating, CD1 females were single housed and randomly assigned to
either a n-3 deficient or a n-3 sufficient diet, both containing 5% fat, in the form of
sunflower oil (rich in LA, the “n-3 deficient diet”) or a mixture of different oils of
which rapeseed oil (rich in ALA, the “n-3 sufficient diet”) throughout gestation and
lactation20 (Tables 2 and 3). The composition of the standard chow diet is closer to
the n-3 deficient diet in terms of LA, total n-6 PUFA, total PUFAs, while it is more
similar to the n-3 sufficient diet in terms of LA/ALA ratio and ALA. Hence, we
used the n-3 sufficient diet as our control as it more consistently contains higher
levels of n-3 PUFAs and lower levels of n-6 PUFAs than the n-3 deficient diet. The
content of proteins, carbohydrates, and lipids varies as well (3.1% of lipids in the
standard chow vs 5% in the n-3 sufficient diet). All experiments were performed on
the offspring from n-3 deficient and n-3 sufficient dams at post-natal day (P) 21.
Pups from different dams were used for each measurement to avoid any cage effect.
Each mother had 2–3 litters and was put back on a standard diet for a minimum of
one month between each litter.
Drugs. Cyclo(Arg-Gly-Asp-D-Phe-Val) (cRGD; Bachem, H-2574) and its control,
scrambled, peptide c(RADfV) (or sc-cRGD; Bachem, H-4088) were dissolved in
acetic acid (1N) and further diluted into aCSF to a final concentration of 1 mM. A
volume of 1 µl of cRGD or sc-cRGD was injected in the CA1 region of the hip-
pocampus, bilaterally, at P14. Animals were euthanized at P21 and processed for
Western blot analysis.
XVA-143 (kindly provided by Hoffmann-La Roche) was dissolved in aCSF at 5
mM. In all, 1 µl was injected bilaterally in the CA1 region of the hippocampus at
P17. Animals were used at P21 for behavioral and biochemical analyses. For
primary microglial cell cultures, XVA-143 was applied 30 min before beads
incubation at a final concentration of 1 µM.
Baicalein (Sigma-Aldrich, #465119) was applied at a final concentration of 20
μM in 0,2% DMSO for ex vivo experiments. For behavioral assessment, baicalein
was injected intraperitoneally at a concentration of 20 mg/kg.
Cortex fatty acid composition. Fatty acid composition was studied in the cortex
(not hippocampus) of animals as: (1) cortex and hippocampus fatty acid compo-
sition vary similarly under the diets used in this study; (2) to reduce the number of
animals. Cortical fatty acids were extracted according to the method of Folch, fatty
acids were transmethylated according to the method of Morrison and Smith and
fatty acid methyl esters (FAMEs) were analyzed on a FOCUS GC gas chromato-
graph (Thermo Electron Corporation) equipped with a split injector and a flame
ionization detector.
Microglia isolation and sorting. Brains were homogenized in Hanks’ Balanced
Salt Solution (HBSS), pH 7.4 passing through a 70 μm nylon cell strainer.
Homogenates were centrifuged at 600 g for 6 min. Supernatants were removed and
cell pellets were re-suspended in 70% isotonic Percoll (GE-Healthcare, Aulnay sous
Bois, France). Single cell suspensions were prepared and centrifuged over a 37%/
70% discontinuous Percoll gradient (GE Healthcare) at 2000g for 20 min, mono-
nuclear cells were isolated from the interface. For each brain extraction ~3 × 105
cells were isolated. Cells were washed and in order to sort resident microglia from
recruited myeloid cells, we used a monoclonal antibody that recognizes FCRLS,
which is expressed on microglia, but not on infiltrating myeloid cells (Butovsky
et al.20). Isolated cells were stained with rat anti-FCRLS [clone 4G11, 3 mg ml1,
validated in Butovsky et al.20] and then followed by a secondary detection using an
anti-rat IgG PE (Biolegend).
Cells were sorted using a FACS Aria 5-Blue 2-Violet 2-Red laser configuration
(BD Biosciences).
Table 2 Fatty acid composition of the diets (% wt of total
fatty acids).
Diets Deficient Sufficient Standard chow
(A04)
16:0 7.3 22.6 20.3
18:0 4.1 3.3 2.2
Other saturated FAs 1.6 1.8 1.8
Total saturated FAs 13.0 27.7 24.3
18:1n-9 28.1 57.9 19.3







18:2n-6 (LA) 57.4 10.6 45.9
Other n-6 PUFAs n.d. n.d. 0.3
Total n-6 PUFAs 57.4 10.7 46.2
18:3n-3 (ALA) 0.2 1.6 3.3
20:5 n-3 n.d. n.d. 0.6
22:5 n-3 n.d. n.d. 0.1
22:6 n-3 n.d. n.d. 0.8
Total n-3 PUFAs 0.2 1.6 4.8
Total PUFAs 57.6 12.3 51.0
LA/ALA 287 6.6 13.9
FAs fatty acids, PUFAs polyunsaturated fatty acids, LA linoleic acid, ALA α-linolenic acid, n.d. not
detected (under the limit for the detection by gas chromatography, <0.05%).
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Ccl3 50,2 Slco2b1 0,55 Ttr 0,35
Ccl4 18,9 Golm1 0,55 BMP6 0,35
Rasgef1b 9,5 A430107D22Rik 0,55 NOX1 0,34
Cd83 5,4 D830030K20Rik 0,54 Nav2 0,34
Atf3 5,3 Vat1l 0,54 Mmp12 0,34
Ccrl2 4,7 LOC100038847 0,54 Hist1h2ac 0,34
C3ar1 4,4 Ifi202b 0,54 Siglec1 0,33
Ccl2 4,1 Rgmb 0,54 Plxna1 0,32
Ppp1r15a 3,5 Ccr5 0,54 Fcrls 0,32
Nlrp3 3,0 ADAM17 0,54 Slco4a1 0,31
Apoe 3,0 Ppp1r9a 0,53 Cbr3 0,31
Rgs1 2,9 Rnf180 0,53 Slc46a1 0,31
Trim47 2,8 FcgrIIIa (CD16a) 0,53 Upk1b 0,29
Adamts1 2,8 P2ry12 0,53 Khdrbs3 0,29
Dab2 2,7 CD200R 0,52 Tnfrsf17 0,29
Klhl38 2,6 Gpr165 0,52 TREM1 0,28
1810011O10Rik 2,6 Fgd2 0,52 ll7r 0,28
CEBPB 2,5 Trem2 0,51 Ak1 0,28
Myc 2,4 P4ha1 0,51 BMP7 0,28
Cd14 2,4 Gtf2h2 0,51 WNT5A 0,27
Fos 2,3 Zfp691 0,51 Kitl 0,24
Il1a 2,3 Tmem144 0,51 Chi3l1 0,22
Rgl1 2,2 Plxna4 0,51 Cfb 0,21
Fosb 2,2 Itgax 0,51 Arg1 0,20
Manba 2,2 Bend6 0,51 Olfml3 0,18
Npl 2,1 Csf3r 0,51 Gal3st4 0,17
cathepsin 2,0 SEMA3C 0,50
Rhob 2,0 Bco2 0,50
Ltc4s 2,0 MPO (myeloperoxidase) 0,50
Egr1 2,0 ENSMUSG00000079376 0,50
Fth1 1,9 Erf 0,50
Abca1 1,9 Tmc7 0,49
Jun 1,9 4933406P04Rik 0,49
Socs3 1,8 Mmp2 0,48
Junb 1,7 Tmem204 0,48
SREBP1 1,7 Tlr3 0,48
Tlr2 1,6 Spnb4 0,47
Il1rl2 1,5 Scoc 0,47
Ctsl 1,5 B930046C15Rik 0,47
9030625A04Rik 1,4 Asph 0,47
SRA1 1,4 WNT7A 0,47
Pycard 0,46
Down-regulated genes Sall1 0,46
Icam1 0,82 Pros1 0,46
HIST1H2AB 0,76 Garnl3 0,46
Ryk 0,75 Fabp5 0,45
Grm1 0,75 MR 0,45
Rtn1 0,75 Camk2n1 0,44
Tfeb 0,74 B4galt4 0,44
Map3k7 0,72 Slc2a5 0,44
Slc24a3 0,71 Il21r 0,43
Qdpr 0,70 IL34 0,43
ADAM10 0,68 Atp8a2 0,43
Cxxc5 0,67 Jam2 0,43
Ckb 0,67 Myo1b 0,42
Ttc28 0,66 Gpr56 0,42
Tmem100 0,66 Ebf3 0,42
Nfia 0,65 Olfml2b 0,42
Tm9sf4 0,65 Fgfr1 0,42
Snn 0,64 Tmem119 0,42
Abi3 0,64 Scamp5 0,42
Epn2 0,64 Fads1 0,41
Sema4d 0,63 Psd 0,41
Map2k1 0,62 Tmeff1 0,41
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Cell culture and treatments. For in vitro phagocytic assays, primary mixed glial
cell cultures were prepared from the cortices of P0–1 CD1 mice. After dissection in
0.1 M PBS with 6% glucose and 2% penicillin–streptomycin (Gibco, Cergy Pon-
toise, France) and removal of the meninges, the cortices were chopped and sub-
sequently mechanically dissociated. The suspension was diluted in low glucose
DMEM (31885, Gibco) supplemented with 10% fetal bovine serum (Gibco) and 1%
penicillin–streptomycin. Microglia were isolated from primary mixed glial cultures
on DIV14 using a reciprocating shaker (45 min at RT) and repeated rinsing with
their medium using a 10 mL pipette. Media was subsequently removed, microglia
pelleted via centrifugation (504 g × 10min) and following resuspension maintained
in DMEM at a concentration of 4 × 105 cells/mL in six-well culture plates. Cells
were then treated for 24 h in serum-free medium containing 50 µmol/L fatty acid-
free bovine serum albumin (BSA) added either with DHA, AA, DPAn-6 or EPA 30
µmol/L in 0.1% ethanol or 0.1% ethanol. For oxylipins, 30 min prior to the pha-
gocytosis assay, culture medium was replaced by serum-free DMEM containing
100 nM of the given lipid in 0.03% ethanol, or 0,03% ethanol.
Phagocytic assay. Ex vivo assays: the phagocytic capacity of microglia was
determined by the level of pHrodo™ Red fluorescence accumulated in the cells.
First, we used pHrodo-conjugated E.Coli bioparticles. A suspension of 2.5 × 105
sorted microglia cells in 100 μL of RPMI/1% BSA was incubated with bioparticles
in an incubator at 37 °C and 5% of CO2 for each time point. Cells were then
pelleted by centrifugation at 1000×g for 10 min at 4 °C, resuspended in 200 μL of
RPMI/1 %BSA and stained with CD11b-APC [clone M1/70, eBioscience] and rat
CD45-PerCP-Cy™5.5 [clone 30-F11, BDBiosciences] antibodies for quantification
by flow cytometry. We also developed a model using pHrodo-conjugated synap-
tosomes as a substrate for the phagocytosis. Synaptosomes were prepared from P21
mice hippocampus, and labeled with pHrodo Red, succinimidyl ester (Thermo
Fisher Scientific, P36600) according to manufacturer instructions. Synaptosomes
were resuspended at a concentration of 10 mg/ml in DMEM. Microglia were plated
at a density of 5.10^5 cells/well in 24-well plates and received 150 μg of synapto-
somes for 120 min in an incubator at 37 °C and 5% CO2. When needed, baicalein
was applied at a final concentration of 20 μM in 0,2% DMSO 90 min prior to the
beginning of the assay (i.e. the addition of synaptosomes). Cells were collected by
gentle trypsin treatment, rinsed and resuspended in PBS/1%BSA buffer to be
stained with CD11b-V450 [clone M1/70, BDBiosciences], CD45 PerCP Cy5.5
[Clone 30-F11, BDBiosciences], Ly6G-APC [clone 1A8, BDBiosciences] and Ly6C-
APC-Cy™7 [clone AL-21, BDBiosciences] both for negative exclusion and analysis
by cytometry. After selection of the CD11b+/CD45low, cells were gated on PE
channel for quantification of pHrodo fluorescence.
Experiments in Figs. 3c and 6f have been performed on the same batches in
order to spare animals. Hence, data used for Fig. 3c control groups are a randomly
chosen subset of Fig. 6f’s data.
In vitro, two different substrates where used: FCS-coated Yelloworange
fluorescent carboxylated microspheres (Fluoresbrite® YO Carboxylate
Microspheres 3.00 µm, Polysciences Europe GmbH, #19393-5) or the pHrodo-
conjugated synaptosomes as described above. To quantify their phagocytic index,
primary microglial cell cultures were incubated with a suspension of microspheres
at a concentration of 1.1 × 107 microspheres/ml for 30 min at 37 °C, intensively
washed, and finally fixed with 4% paraformaldehyde. Cells were stained with anti-
Iba1 antibodies. A blinded experimenter counted beads per cell using NIS Elements
AR 3.26 software. To measure phagocytic activity by cytometry, cells were
incubated for 60 or 120 min with 150 µg of synaptosomes per well. Medium was
removed and cell collected following trypsin treatment, pelleted, rinsed in PBS/1%
BSA, and stained with CD11b-FITC [clone M1/70, BDBiosciences] antibody for
cytometry analysis.
FACS data were acquired using an LSR Fortessa 2-Blue 6-Violet 3-Red 5-YelGr
laser configuration (BD Biosciences). Diva 8.0 (BD Biosciences) and FlowJo 10.5
(FlowJo, LLC) were used for data analyses.
Microglia fatty acid analysis. Fatty acid analyses requiring lots of material, we
pooled microglia from 4 brains for n= 1. Based on our experience, we sort 400,000
cells out of the brain of P21 mice, hence measurements were made on around 1.6
million microglia. It is noted in ng/sample in the legend.
Fatty acids: Extraction and quantification of total fatty acids by GC-FID:
Microglia from 3 to 4 brains per sample were lysed in 100% methanol and
extracted via from the Folch method (2:1:0.8 chloroform: methanol: 0.88% KCl)
and analyzed by a Varian-430 gas chromatograph (Varian, Lake Forest CA).
Lipid mediators: Isolation and quantification of brain eicosanoids and
docosanoids by LC-MS-MS: Pooled microglia extracted from 3 to 4 brains per
sample were lysed in 15% methanol and stored at −80 °C prior to analysis. One ng
of internal standard mixture was added to each sample, and lipid mediators were
extracted, analyzed by LC-MS-MS and quantified as previously described87.
Synaptosomes preparation and fatty acid quantification. Synaptosomes were
prepared from P21 mice hippocampus88. The two hippocampi of each animal were
dissected and placed in 1 mL of ice-cold iso-osmolar buffer. The tissues were
homogenized with 2 cm3 rotating potter with 12 strokes at 900 rpm. The homo-
genate was centrifuged at 1000×g for 5 min at 4 °C, the supernatant was collected in
a new tube and centrifuged at 12,500 × g for 8 min at 4 °C. The supernatant was
removed and the pellet resuspended with 1 mL of ice-cold iso-osmolar buffer. The
discontinuous sucrose gradients were prepared in ultracentrifuge tubes with ice-
cold 1.2 M sucrose solution and 0.8 M sucrose solution. The resuspended pellet was
placed on top of the sucrose gradient. The centrifugation at 50,000 × g for 1 h at





Zfpm1 0,62 Ptprm 0,41
Rbbp9 0,62 Tlr5 0,40
Adora3 0,62 Adamts16 0,40
Ang 0,61 Eng 0,40
Gpr34 0,61 CD36 0,39
Rtn4rl1 0,61 Itga9 0,39
Bin1 0,60 Gpr40 0,39
Acp2 0,60 Tspan18 0,39
Epb4.1l2 0,60 Ecscr 0,39
Cttnbp2nl 0,60 Cntn1 0,39
Itgb5 0,59 WNT2 0,39
Sgce 0,58 Gp9 0,38
D18Ertd653e 0,58 Arhgap22 0,37
Gm10790 0,57 Pon3 0,37
Tjp1 0,57 Plxdc2 0,37
Spsb1 0,57 Tanc2 0,37
C3 0,57 Rab6b 0,36
Lair1 0,57 Kcnd1 0,36
Tppp 0,57 Csmd3 0,36
IL6ST 0,56 NRG1 0,36
Cx3cr1 0,56 Capn3 0,35
Siglech 0,56
Only genes with P < 0.05 are considered significant.
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(synaptosomes) was collected with a syringe. Synaptosomes were then rinsed with
100 mM pH 8.5 sodium bicarbonate buffer and stored for further experiments.
Fatty acid quantification was run as already explained for the cortex fatty acid
composition (see above).
RNA isolation and Nanostring RNA counting. Total RNA was extracted from
isolated microglia using mirVanaTM miRNA isolation kit (Ambion) according to
the manufacturer’s protocol. We performed nCounter multiplexed target profiling
of 542 microglial transcripts (MG550). MG550 encompasses 400 unique and
enriched microglial genes we have identified previously20 and additional 150
inflammation-, inflammasome- and phagocytosis-related genes. In all, 100 ng of
total RNA per sample were used in all described nCounter analyses according to
the manufacturer’s protocol20.
Network analysis. To investigate gene coexpression relationships between groups,
a pairwise transcript-to-transcript matrix was calculated in the software tool Miru
(Kajeka, UK) from the set of differentially expressed transcripts using a Pearson
correlation threshold r= 0.85. A network graph was generated where nodes
represent individual probe sets (transcripts/genes), and edges between them cor-
relation of expression pattern with Pearson correlation coefficients above the
selected threshold. The graph was clustered into discrete 6 groups of transcripts
sharing similar expression profiles using the Markov clustering algorithm
(inflation 2.2).
Electron microscopy. Mice were anesthetized with sodium pentobarbital (80 mg/
kg, i.p.) and perfused with 0.2% glutaraldehyde in 4% PFA. Transverse sections of
the brain (50 µm thick) were cut in PBS (50 mM at pH 7.4) using a vibratome and
stored at −20 °C in cryoprotectant solution (30% glycerol and 30% ethylene glycol
in PBS).
Sections were washed in PBS and quenched with 0.3% H2O2 in PBS for 5 min
and then with 0.1% NaBH4 for 30 min at room temperature (RT), washed in
Tris–buffered saline (TBS; 50 mM at pH 7.4) and processed freely-floating for
immunoperoxidase staining. Sections were pre-incubated for 1 h at RT in a
blocking solution of TBS containing 10% fetal bovine serum, 3% bovine serum
albumin, and 0.01% Triton X100, before overnight incubation at 4 °C in rabbit
anti-Iba1 antibody (1:1000; Wako Pure Chemical Industries) and rinsed in TBS.
After incubation for 1.5 h at RT in goat anti-rabbit IgGs conjugated to biotin (1:200
in blocking solution; Jackson Immunoresearch) and for 1 h with ABC Vectastain
mix (1:100 in TBS; Vector Laboratories), the labeling was revealed using
diaminobenzidine (DAB; 0.05%) and hydrogen peroxide (0.015%) in TBS. After
immunostaining, sections were post-fixed flat in 1% osmium tetroxide and
dehydrated in ascending concentrations of ethanol. They were treated with
propylene oxide, impregnated in Durcupan (EMS) overnight at RT, mounted
between ACLAR embedding films (EMS), and cured at 55 °C for 72 h. Areas of
CA1 stratum radiatum were excised from the embedding films and re-embedded at
the tip of resin blocks. Ultrathin (65–80 nm) sections were cut with an
ultramicrotome (Leica Ultracut UC7), collected on bare square-mesh grids, and
examined at 80 kV with a FEI Tecnai Spirit G2 transmission electron microscope.
Pictures were randomly taken at 9300X in the CA1 stratum radiatum of each
animal, for a total surface of ~2000 µm2 of neuropil captured per animal, using an
ORCA-HR digital camera (10 MP; Hamamatsu). Cellular profiles were identified
according to criteria previously defined89. For quantitative analysis, each captured
Iba1-positive microglial process was analyzed. A phagocytic index was compiled by
summing up the vacuoles and endosomes containing cellular materials such as
membranes, axon terminals with 40-nm synaptic vesicles and dendritic spines with
a postsynaptic density, on a microglial process basis16. Images were analyzed using
the AMT Image Capture Engine Software 601.384.
Immunohistochemistry. Mice were deeply anesthetized with isoflurane and
transcardially perfused with PBS followed by 4% PFA. Brain was removed, post-
fixed in PFA overnight at 4 °C and cryoprotected in 30% sucrose at 4 °C. Immu-
nohistochemistry experiments were performed on free-floating coronal 30 μm
cryostat slices. The following antibodies were used: 1:1000 rabbit anti-Iba1 (Wako,
#019-19741), 1:100 mouse anti-PSD95 (www.anticorps-en-ligne.fr, ABIN1304920),
1:500 rat anti-CD11b (AbD Serotec, #MCA711), 1:500 rabbit anti-C1q (Abcam,
#ab182451), 1:20 mouse anti-C3aR (Hycult biotech, #HM1123), 1:1000 rabbit anti-
GFAP (Dako, Z03334), 1:1000 mouse anti-NeuN (Millipore, #MAB377),1:200
rabbit anti-Annexin V (Abcam, #ab14196), 1:500 mouse anti-claudin 5 (Life
Technologies: Invitrogen), 1:500 IRDye 800 conjugated affinity purified goat-anti-
mouse IgG (Rockland, Gilbertsville, PA). Primary antibodies were visualized with
appropriate secondary antibodies conjugated with Alexa fluorophores (Invitrogen)
and counterstained with DAPI or with biotin. When biotinylated, secondary
antibodies were revealed using the streptavidin-biotin-immunoperoxidase techni-
que, giving a black precipitate.
Image analysis. Densitometry: Individual images were analyzed with Fiji or Image
J software (Image J, open source), using the following procedure: (1) user-defined
thresholding value applied to each image, (2) calculation of area of staining from
background for each protein of interest. Final values are represented as a surface
area in pixel values. Control sections for all studies in which primary or secondary
antibodies were omitted resulted in negative staining (not shown).
Stereological analysis: Iba1- and GFAP-immunoreactive cell numbers and
volume of the hippocampus were thoroughly determined in the hippocampus with
the unbiased stereological sampling method based on optical dissector
stereological probe.
Apoptotic cells counting: The number of apoptotic cells (cells with pycnotic/
karryorhectic morphology) was estimated using unbiased stereology methods, and
is reported as cells/mm3.
Quantitative real-time PCR. Total RNA was extracted from hippocampi using
TRIzol (Invitrogen, Life TechnologiesTM). RNA purity and concentration were
determined using a Nanodrop spectrophotometer (Nanodrop technologies, Wil-
mington, DE). In all, 2 μg of RNA was reverse transcribed to synthesize cDNA using
Superscript III (Invitrogen, Life TechnologiesTM) and random primer according to
the manufacturer’s protocol. Quantitative PCR were performed on 384-well plates
using epMotion 5070 (Eppendorf). 10 µl of cDNA diluted 1:5 (20 ng/µl) were
amplified by real-time PCR. Primer references: C1qa Mm00432142_m1; C3
Mm00437838_m1; TREM2 Mm00451744_m1; CD11b Mm01271262_m1 (for
in vitro experiments); CD33 Mm00491152_m1; CX3CR1 Mm00438354_m1;
CX3CL1 Mm00436454_m1; TGFb Mm03024053_m1; beta-2 microglobulin
Mm00437762_m1 (housekeeping gene) (Life Technologie). For in vivo quantifica-
tion of CD11b mRNA expression, we used SYBR Green technology. Ten µl of
cDNA diluted 1/60 (1.66 ng/µL) were amplified by real-time PCR. Primers
sequences: CD11b Forward AATGATGCTTACCTGGGTTAT GCT/Reverse TGA
TAC CGA GGT GCTCCTAAAAC; Housekeeping gene beta-2 microglobulin:
Forward CTGATACATACGCCTGCAGAGTTAA/Reverse GATC
ACATGTCTCGATCCCAGTAG. For all experiments, the difference between target
and housekeeping gene Ct values (ΔCt) was calculated to normalize for differences
in the amount of total nucleic acid added to each reaction and in the efficiency of
the RT step. The expression of target gene (linear value) normalized to the
housekeeping gene was determined by 2−(ΔCt).
Droplet digital (dd)PCR. Total RNA was extracted using the RNeasy® micro Kit
(Qiagen, Germany) according to the manufacturer’s protocol. The integrity of the
RNA was checked by capillary electrophoresis using the RNA 6000 Pico Labchip
kit and the Bioanalyser 2100 (Agilent Technologies, Massy, France), and quantity
was estimated using a DS.11 (DeNovix, USA). The RNA integrity number (RIN)
was above 7,5. cDNA was synthesized from 6 ng of total RNA using Qscript XLT
cDNA supermix (QuantaBio). Quantitative PCR was used for the choice of the
reference gene and perfomed using a LightCycler® 480 Real-Time PCR System
(Roche, Meylan, France). Quantitative PCR reactions were done using transcript-
specific primers, cDNA, and LightCycler 480 SYBR Green I Master (Roche) in a
final volume of 10 μl. For the determination of the reference gene, the Genorm
method was used. The elongation factor 1-alpha 1 (Eef1a1) and peptidylprolyl
isomerase A (Ppia) genes were used as reference genes.
ddPCR was used for the quantification of the interest genes. PCRs were prepared
with cDNA and the required QX200 ddPCR EvaGreen Supermix (Bio-Rad) with a final
concentration of 150 nM for each transcript-specific primer to a final volume of 20 µl.
Each reaction was loaded into a sample well of an 8-well disposable cartridge (Bio-Rad)
followed by 70 µl of droplet generator oil (Bio-Rad), which was added to the oil wells of
the cartridge. Droplets were formed in the QX200 droplet generator (Bio-Rad). Droplets
were then transferred to a 96-well PCR plate, heatsealed with foil in a PX1 PCR Plate
Sealer Bio-Rad and amplified with an Eppendorf Nexus Gradient master cycler (95 °C
primary denaturation/activation for 5min, followed by 45 cycles of 95 °C for 30 sec and
61 °C for 1min, followed by 4 °C 5mn and a final 90 °C heat treatment for 5min).
PCRs were analyzed with the QX200 droplet reader (Bio-Rad) and data analysis was
performed with QuantaSoft software (version 1.7; Bio-Rad). qPCR primer sequences:
Eeflal (GenBank NM_010106): Forward TGAACCATCCAGGCCAAATC, Reverse:
GCATGCTATGTGGGCTGTGT; Ppia (GenBank NM_008907): Forward
CAAATGCTGGACCAAACACAA, Reverse: GCCATCCAGCCATTCAGTCT; C3ar1
(GenBank NM_009779): Forward TCCCATCTCTCCCTACTTTGCA, Reverse:
TGTTTTAGGCACACCATGGTAAA; Itgam (GenBank NM_001082960): Forward
CTCATCACTGCTGGCCTATACAA, Reverse: GCAGCTTCATTCATCATGTCCTT;
Gpr31b (GenBank NM_001013832): Forward GCTGCAGTGTCCAGCAAGC,
Reverse: TGTACTGTGCAGGCAGGTGAG.
Golgi staining. Brains were processed for Golgi-Cox staining using the FD Rapid
Golgi Staining kit (FD Neurotechnologies, Inc). Brains were left in the staining
solution for 12 days, frozen in isopentane solution and kept at −80 °C until sec-
tioning and coloration. The brains were cryostat-cut at a thickness of 100 μm.
Sections were mounted on gelatin-coated slides and analyzed using a motorized
Leica DM5000 microscope at ×63 magnification. The images were acquired using a
CCD Coolsnap camera and Metamorph software. For analysis, we randomly
selected pyramidal neurons from the CA1 region of the dorsal hippocampus that
were fully penetrated by the Golgi coloration and distinguishable from other
neurons (n-3 deficient mice had less usable neurons than n-3 sufficient mice).
Spine density in these neurons was determined by counting the number of spines
on at least 3 basal and 3 apical dendritic segments of 10 μm in length. Segments
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from dendrites situated as far from the cell body as possible, with no overlap with
other dendrites were randomly selected. Primary dendrites were never used for
analysis as their thickness hampers detection of spines. Spine density was calcu-
lated per 10 μm and averaged across the different segments in the same neuron.
Images were processed with Mercator Pro 7.9.11.
Western blotting. Brains were carefully placed on a glass plate over dry ice to
collect hippocampi that were immediately frozen and stored at − 80 °C until use.
Samples were homogenized in lysis buffer plus anti-phosphatase solution (Tris/HCl
20 mM pH 7.4 with EDTA 1mM, MgCl2 5 mM, dithiothreitol 1 mM, Na ortho-
vanadate 2 mM, protease inhibitors cocktail 1X and Na fluoride 1 mM). Homo-
genates were centrifuged 10 min at 2200 × g to remove nuclei. Supernatants were
stored at −80 °C. Protein contents were determined by Bio-Rad protein assay
according to the manufacturer’s protocol (Bio-Rad) and then heated to 100 °C for
5 min in Laemmli sample buffer (2% sodium dodecyl sulfate and 5%
dithiothreitol).
Equal quantities of proteins (20 μg/well) were electrophoresed onto an 8% or
12% polyacrylamide gel with a 4% stacking gel. Proteins were blotted on PVDF
membranes (Immobilon, Millipore, Paris, France). Membranes were saturated by
incubation with 5% milk in TBS and Tween 0.1% for 1 h. Blots were probed
overnight at 4 °C with 1:1,000 rabbit anti-PSD95 (Cell signaling Technology, 3450
S), 1:500 rabbit anti-Bax (Santa cruz, SC-493), 1:500 rabbit anti-Bcl2 (Santa Cruz
Biotechnology, SC-492), 1:1,000 mouse anti-Mer (R&D systems, AF591), 1:1,000
mouse anti-Axl (R&D systems, AF854), 1:1,000 rabbit anti-ERK1/2 (Cell Signaling
Technology, 137F5), 1:500 goat anti-MFG-E8 (R&D systems, AF2805), 1:1000
rabbit anti-GluA1 (Santa Cruz Biotechnology, SC-28799), 1:1000 rabbit anti-GluA2
(Santa Cruz Biotechnology, SC-7611), 1:1000 goat anti-GluN2A (Santa Cruz
Biotechnology, SC-1468), 1:1000 goat anti-GluN2B (Santa Cruz Biotechnology, SC-
1469), 1:1000 rabbit anti-GluN1 (Santa Cruz Biotechnology, SC-31556), 1:5000
rabbit anti-SAP102 (Synaptic System, 124213), 1:300 mouse anti-cofilin (Abcam,
Ab-54532), 1:5000 rabbit anti-actin (Cell Signaling Technology, 4967), 1:5000
rabbit anti-GAPDH (Cell Signaling Technology, 2118S). After washing in TBS-
Tween, membranes were incubated with the secondary antibody coupled to Horse
Radish Peroxidase (HRP, Southern Biotechnology Associates, Birmingham, AL,
USA) diluted in TBS-Tween supplemented with 3% milk, for 2 h at room
temperature. Membranes were washed and the complex was detected with an ECL
kit (ElectroChemoLuminescence, Amersham, Orsay, France). Optical density
capture of the signal obtained was performed with the Syngene Chemigenius2
apparatus (Synoptics, Cambridge, UK). Intensity of the signal was quantified using
GeneTools software (Synoptics, Cambridge, UK).
C3 ELISA assay. The level of C3 protein located on synaptosomes was measured
using the Mouse C3 (Complement Factor 3) ELISA Kit (Genway Biotech GWB-
7555C7). Synaptosomes were prepared using the hippocampi of 2 mice per sample.
After extraction, synaptosomes were lysed using sonication in TB. Quantifications
were performed according to manufacturer instructions, in duplicates and by
loading 5 μg of proteins extract per well, and using the following software Wallac
1420 instrument Workout 2.5 (PerkinElmer).
Y maze task. P21-old mice were handled daily and weighed before and during
behavioral experiments. Sessions were recorded with a ceiling-mounted video
camera and analyzed using Smart software (Panlab, Barcelona, Spain). The Y-maze
was used to assess spatial working memory90. Each arm was 34 cm long, 8 cm wide,
and 14 cm high. The floor of the maze was covered with corn cob litter, which was
mixed between each trial to remove olfactory cues. Visual cues were placed in the
testing room and kept constant during the whole test. In the first trial, one arm was
closed with a guillotine door and mice were allowed to visit two arms of the maze
for 5 min. After a 30-min to 3 h inter-trial interval (ITI), mice were placed back in
the start arm and allowed free access to the three arms for 5 min. Start and closed
arms were randomly assigned for each mouse. When required, baicalein was
injected intraperitoneally at a concentration of 20 mg/kg, at P14, P17, and 30 min
prior the first trial (at P21 or P30 depending on the experiments). Data are pre-
sented as the time spent exploring the novel and the familiar arms during the
second trial.
Statistical analyses. For most experiments, experimental groups were compared
using Student t-test or non-parametric Mann-Whitney test (when equality of
variance or normality failed). We used the Grubbs’ test, also called the ESD method
(extreme studentized deviate), to determine whether the most extreme value in the
list is a significant outlier from the rest. Paired t-tests were used for Y-maze
experiments (familiar vs novel arm for each experimental group). A two-way
ANOVA was used for XVA-143, cRGD, and baicalein experiments (except Y-
maze), ex vivo and in vitro phagocytic activity. All data were expressed as means ±
standard error of the mean (SEM). A p < 0.05 was considered as statistically sig-
nificant. Statistics were performed using GraphPad Prism 7.0.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data are provided with this paper. All data supporting the findings are provided
within this paper and its supplementary information. Fatty acids derivatives data are
available on Metabolights. Our study is identified as MTBLS1952. Transcriptomic data
are available in the GEO database. Accession number: GSE158181.
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